|1.||Carrington, Mary: 20 articles (06/2014 - 08/2002)|
|2.||Mallal, Simon: 18 articles (01/2015 - 03/2004)|
|3.||Walker, Bruce D: 18 articles (12/2014 - 12/2004)|
|4.||Pirmohamed, Munir: 13 articles (08/2015 - 06/2004)|
|5.||Brander, Christian: 12 articles (11/2015 - 12/2004)|
|6.||Hung, Shuen-Iu: 11 articles (12/2015 - 04/2004)|
|7.||Oka, Shinichi: 11 articles (07/2015 - 01/2005)|
|8.||Takiguchi, Masafumi: 11 articles (07/2015 - 01/2005)|
|9.||Goulder, Philip J R: 11 articles (12/2014 - 12/2004)|
|10.||Chung, Wen-Hung: 10 articles (12/2015 - 04/2004)|
02/01/2011 - "To determine the frequencies of HLA-B alleles in Ugandan patients in the NORA substudy of the DART trial and to compare HLA-B allele frequencies in those with and without clinically diagnosed hypersensitivity reaction (HSR). "
04/01/2008 - "This paper outlines the design of a study to evaluate the utility of prospective screening for HLA-B*5701 to reduce the incidence of ABC hypersensitivity in an ABC-naïve population of HIV-infected subjects. "
01/01/2014 - "HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity."
12/01/2013 - "Suspected hypersensitivity reactions were the main cause of discontinuation due to intolerance (27.6%); the rate was 3.8% when ABC had been introduced before the routine use of the screening test HLA-B*5701. "
09/01/2013 - "This patient had no previous food or medication allergy history and presented a negative test result of HLA-B*1502 genotype. "
12/01/2013 - "The aim of this study was to assess the role of HLA-B*27 and it's subtypes in determining severity and clinical manifestations of ankylosing spondylitis (AS).A total of 163 AS patients were assessed for clinical manifestations and severity using structured questionnaires. "
01/01/2013 - "Profiling of hla-B alleles for association studies with ankylosing spondylitis in the chinese population."
04/01/2011 - "A polymerase chain reaction with specific sequence primer method were used to study the HLA-B* locus polymorphism in 50 Syrian patients fulfilling the modified New York criteria for classification of ankylosing spondylitis and 217 unrelated healthy Syrian controls. "
03/01/2011 - "The aim of this study was to determine whether the HLA-B*27 polymorphisms confer susceptibility to ankylosing spondylitis (AS) in Han populations by conducting a meta-analysis. "
04/01/2015 - "The human MHC class I protein HLA-B*27:05 is statistically associated with ankylosing spondylitis, unlike HLA-B*27:09, which differs in a single amino acid in the F pocket of the peptide-binding groove. "
10/01/2015 - "Compared with the previous retrospective cohort study, a significant reduction in SCARs was observed in HLA-B*58:01-positive patients (0 vs. 18%; P = 0.002). "
04/01/2015 - "The aim of our study was to determine the frequency of HLA-B(*)1502 in SCARs patients at a large University Medical Center in Hanoi, Vietnam. "
04/01/2015 - "In other Asian countries, HLA-B(*)1502 is an established risk factor for SCARs. "
05/01/2013 - "There was no association between the HLA-B*1502 and aromatic anticonvulsant-induced severe cutaneous adverse reactions (SCARs). "
01/01/2015 - "Prospective screening of the HLA-B*58:01 allele, coupled with an alternative drug treatment for carriers, significantly decreased the incidence of allopurinol induced SCARs in Taiwanese medical centres."
09/10/2011 - "The fact that such adaptations are driven by the HLA-B molecules that provide best protection against HIV-1 disease progression has important implications for our understanding of HIV evolution."
01/01/2016 - "HLA-B*46 was not associated with disease progression. "
01/01/2016 - "We hypothesized that alleles predicted to confer more effective immune responses, such as HLA-B*46, would protect against disease progression. "
07/01/2015 - "We sought to determine the role of HLA-B allele frequency on rapid HIV disease progression. "
09/01/2014 - "The observed lower replication rate in HLA-B*5701 subjects with higher baseline CD4+ T cell counts provides a potential model to explain differences in risk of disease progression among individuals carrying this allele. "
01/01/2013 - "The risk profile of polymorphisms at position 97 of HLA-B are more broadly associated with HIV-1 viral load during primary infection and may serve as a focal point in further studies of HLA-B function."
01/01/2013 - "This study sought to determine the role of HLA-B alleles in viral control during the acute phase of HIV-1 infection and establishment of the early viral load set point (VLSP). "
09/01/2012 - "The present study investigated HIV-1 in vivo evolution and epitope-specific CD8(+) T cell responses in six HLA-B*5701 patients who had not received antiretroviral treatment, monitored from early infection for up to 7 years. "
08/01/2012 - "The aims of this study were to evaluate the variants in HLA-B associated transcript 2 (BAT2), CXCL12, myxovirus resistance protein 1 (Mx1) and EHMT2 genes and their effects on the risk of infection PRRSV and H. "
10/01/2009 - "In this study of pediatric infection, we tested the hypothesis that children may tend to progress relatively slowly if either they themselves possess one of the protective HLA-B alleles or the mother possesses one of these alleles, thereby transmitting a low-fitness virus to the child. "
|2.||HLA-A Antigens (HLA-A)
|3.||HLA-C Antigens (HLA-C)
|5.||HLA-DRB1 antigen (HLA DRB1)
|6.||HLA-DQB1 antigen (HLA DQB1)
|9.||HLA-B27 Antigen (HLA B27 Antigen)
|2.||Transplantation (Transplant Recipients)
|3.||Highly Active Antiretroviral Therapy (HAART)
|4.||Homologous Transplantation (Allograft)